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In Brief TM helix VII of b 2 AR mediates cellular signaling via the b-arrestin pathway. Using an in vitro single-molecule fluorescence system, Lamichhane et al. present evidence that a b-arrestin-biased agonist induces signaling bias by controlling the kinetics of exchange between inactive and active-like conformations of TM VII.
INTRODUCTION
G-protein-coupled receptors (GPCRs) are integral membrane proteins that bind extracellular ligands and transmit signals across the cell membrane to intracellular effectors, such as G proteins and b-arrestins (Kobilka, 2011; Peterson and Luttrell, 2017; Shenoy and Lefkowitz, 2011; Thal et al., 2018) . The GPCR superfamily contains more than 800 members in the human proteome and mediates a multitude of physiological functions. Accordingly, GPCRs are the targets for a myriad of drugs (Hopkins and Groom, 2002; Jacobson, 2015; Hauser et al., 2017; Sriram and Insel, 2018) , which account for roughly 30% of all pharmaceutical agents approved by the Food and Drug Administration. Many GPCRs signal through both G-protein and b-arrestin signaling pathways (Rajagopal et al., 2010) . Whereas some drug ligands stimulate both pathways equally (balanced agonists), other ligands selectively stimulate either the G-protein or b-arrestin pathway, a phenomenon termed ''functional selectivity'' or ''biased signaling'' (Correll and McKittrick, 2014; Wisler et al., 2014; Smith et al., 2018) . Selectively stimulating just one of the signaling pathways could mitigate undesirable side effects resulting from activation of the other pathway. As such, biased signaling is of keen interest for the next generation of GPCRbased therapeutics (Smith et al., 2018) . For example, agonists of opioid receptors that selectively activate the G-protein pathway could provide effective and safe pain relief while avoiding respiratory failure and dependency associated with activation of the b-arrestin pathway (Soergel et al., 2014; Schmid et al., 2017) , which is of key importance in view of the opioid crisis in the United States (Baumann et al., 2018; Kurland, 2018) . Further studies of the molecular basis of biased signaling are therefore timely and of keen interest.
At the structural level, functional selectivity may arise if different classes of ligands stabilize distinct receptor conformations that are differentially recognized by G proteins or b-arrestins. Consistent with this hypothesis, double electron-electron resonance spectroscopy has shown that Gq-biased ligands stabilize conformations of the angiotensin II type 1 receptor that are distinct from those stabilized by b-arrestin-biased ligands (Wingler et al., 2019) . Moreover, fluorescence-based studies of the vasopressin type 2 receptor (V2R) have shown that Gs-biased ligands shift the position of transmembrane helix VI (TM VI) relative to the receptor C terminus, whereas b-arrestin-biased ligands alter the position of TM VII (Rahmeh et al., 2012) . Nuclear magnetic resonance (NMR) spectroscopic studies of b 2 AR labeled with 19 F probes at the intracellular tips of TM VI or TM VII revealed that the b-arrestin-biased ligand isoetharine (Drake et al., 2008) preferentially affects the conformational state of TM VII. These studies suggest that b-arrestin bias is mediated by the conformational state of TM VII. This hypothesis is corroborated by structural studies showing that b-arrestin engages GPCRs via TM VII. For example, the crystal structure of rhodopsin bound by arrestin reveals that a ''fingerloop'' of arrestin engages TM VII of rhodopsin (Kang et al., 2015) . TM VII was also observed as a trigger for biased signaling in both k-opioid receptor and serotonin receptor systems McCorvy et al., 2018) .
The aforementioned 19 F NMR study of b 2 AR resolved inactive and active-like conformational states of TM VII that coexist in equilibrium, and compared the effects of balanced ligands (with respect to G-protein or b-arrestin pathways) and biased ligands (with respect to the b-arrestin pathway) on the conformational equilibrium . Notably, binding of the b-arrestin-biased agonist isoetharine shifted the conformational equilibrium almost completely to the active-like state of TM VII, whereas the balanced agonist formoterol induced a smaller population shift. Here, we now used a single-molecule fluorescence assay (Lamichhane et al., 2015) to elucidate the kinetic basis of the observed conformational bias induced at TM VII by isoetharine. We chemically attached a Cy3 fluorophore to a cysteine residue on TM VII and showed that this could be achieved without disrupting binding of prototypical b 2 AR ligands. The labeled receptor was reconstituted in phospholipid nanodiscs, attached to a quartz surface, and monitored over time at the single-molecule level by total internal reflection fluorescence (TIRF) microscopy. We observed that TM VII spontaneously fluctuates between one inactive and one active-like conformation, both in the absence and presence of agonist ligands. From statistical analysis of a sizable collection of receptor molecules, we determined the mean dwell times of inactive and active-like TM VII conformers in the apo state, with the balanced agonist formoterol bound and with the b-arrestin-biased agonist isoetharine bound. Notably, isoetharine prolonged the dwell time of the active conformation of TM VII to a greater extent than formoterol, explaining the large population shift toward the active state reported in the earlier NMR spectroscopic study . Since a prolonged dwell time in the active conformation would favor coupling of TM VII to a b-arrestin effector, our results suggest that ligand-dependent changes in the kinetics of receptor conformational exchange contribute to signaling bias.
RESULTS
b 2 AR Constructs Three variants of b 2 AR were used, which are described in detail at the outset of STAR Methods. ''b 2 AR'' is closely related to the wild-type protein, while in ''b 2 AR [AA]'' two surface-exposed cysteines were replaced by alanines, and in ''b 2 AR [AA-Cy3]'' the native cysteine at position 327, near the cytoplasmic tip of TM VII, was covalently labeled with the fluorophore Cy3.
Conformational Modeling of Cy3-b 2 AR Conjugate
Since b 2 AR labeled with Cy3 at position 327 has to our knowledge not been prepared to date, we performed molecular modeling to determine how the Cy3 moiety could be accommodated in the inactive and active receptor conformations and to predict the corresponding local fluorophore environ-ments. A model of the inactive receptor, based on the crystal structure of b 2 AR in complex with an antagonist (Cherezov et al., 2007) , shows that the side chain of Cys327 is facing toward the receptor surface, such that the attached Cy3 moiety is fully solvent exposed and can adopt a range of different positions of similar energy ( Figure 1A) . In contrast, a model of the active receptor, based on a b 2 AR-agonist complex (Rasmussen et al., 2011) , shows that Cys327 is oriented toward the interior of the TM helical bundle, such that the Cy3 moiety is sequestered within a narrow channel surrounded by TMs II, V, and VI ( Figure 1B ). Furthermore, the modeling results suggest that the Cy3 probe can be accommodated within the active receptor conformation with only minor adjustments around the probe site (<2.0 Å for the Cys327-C a atom), suggesting that the presence of the probe does not induce significant conformational strain in the receptor ( Figure 1B) . These results suggested that the Cy3 moiety could be accommodated in either of the two receptor conformations.
Ligand Binding Properties
Saturation binding assays employing the radiolabeled ligand [ 3 H] CGP-12177 and various b 2 AR constructs reconstituted in phospholipid nanodiscs showed that ligand binding is maintained in the receptor construct with attached Cy3 label (Figures 1C-1E  and Table S1 ). Moreover, the dissociation (K D ) values are similar to the values reported for binding of this ligand to b 2 AR in membranes , indicating that the nanodisc environment preserves the ligand binding seen in the natural environment. Competition binding experiments confirmed that the affinity of the agonist formoterol for the receptor was also unaffected by the Cy3 label (Figures 1F-1H and Table S1 ). On the basis of these data, we conclude that the Cy3 fluorophore attached to the cysteine in position 327 does not impair the physiological ligand binding ability of the receptor.
Single-Molecule Fluorescence Measurements
Individual Cy3-labeled receptor molecules reconstituted in phospholipid nanodiscs ) were attached to a quartz microscope slide and monitored over time by singlemolecule TIRF (smTIRF) microscopy (Lamichhane et al., 2015) . Traces of Cy3 emission intensity versus time of individual receptor molecules in the ligand-free apo form show reversible transitions between two discrete intensity states (three representative examples are shown in Figure 2A ). Hidden Markov modeling showed that all time traces are adequately fitted with the assumption that there are two states (shown by the red lines in Figure 2A ). The higher-intensity state is assigned to an activelike conformation of TM VII (state A), based on the conformational modeling of the Cy3-b 2 AR conjugate, indicating that the Cy3 moiety is buried within the TM helical bundle in the conformation of the agonist complex ( Figure 1B ). In such a restricted local environment, excited-state cis-trans isomerization of Cy3 will be inhibited, giving rise to an increased fluorescence quantum yield. This phenomenon is well known as protein-induced fluorescence enhancement (PIFE) (Stennett et al., 2015) . The lower-intensity state is assigned to the receptor in an inactive conformation (state I), consistent with the modeling results showing that the Cy3 moiety is solvent exposed and can adopt a range of different positions in the antagonist complex ( Figure 1A) . No fluorescence enhancement is expected under these conditions. The observed effects of agonist ligands on the dwell times of the two intensity states (described below) are consistent with these assignments.
Information on the kinetics of switching between inactive and active-like states of TM VII was obtained from dwell time analysis. Dwell time histograms for the activation transition (state I to A) and deactivation transition (state A to I), compiled from In the predicted lowest energy conformation, the Cy3 moiety (CPK representation) is located in an unrestricted solvent-exposed environment. Alternative Cy3 conformations lying within 4 kJ/mol of the lowest energy conformation are shown as thin gray lines. (B) Model based on a receptor-agonist complex (PDB: 4SN6, red ribbon). In the predicted lowest energy conformation, the Cy3 moiety fits into a shallow cavity formed by TMs II, V, and VI. An energy-optimized conformation of the Cy3-conjugated receptor is also shown (orange ribbon). Comparison of the orange and red models suggests that, despite its location in the protein interior, the Cy3 probe can be accommodated within the active receptor conformation with only minor adjustments in the Cys327 region and does not lead to any substantial conformational strain on the receptor. (C) Saturation binding of radioligand [ 3 H]CGP-12177 to b 2 AR in nanodiscs, as reported previously (Lamichhane et al., 2015) . Levels of total binding (circles) and non-specific binding (squares) are shown separately. The solid lines are best-fit curves, obtained as described in STAR Methods. The corresponding equilibrium dissociation (K D value) is indicated. Error bars shown are from triplicate measurements. multiple receptor molecules in the apo form, are shown in Figures 3A and 3B, respectively. Both histograms show a rapid initial decay, followed by a tail extending to longer dwell times; a precise fit for both histograms was obtained with a doubleexponential function (Equation 1) (red lines in Figures 3A and  3B) . The slow kinetic phase accounts for 6%-26% of the total amplitude and reflects a subpopulation of receptors that switch between states relatively slowly. Two populations were also observed for b 2 AR labeled with Cy3 in TM VI (Lamichhane et al., 2015) . In that case, the slowly interconverting species was assigned to a non-functional population of b 2 AR molecules, since it has been reported that nanodisc reconstitution of b 2 AR results in the loss of $30% of starting activity (Leitz et al., 2006) . Because the minor kinetic component likely reflects a non-functional population of b 2 AR [AA-Cy3] molecules, hereafter we focus on the major population exhibiting rapid conformational switching. The mean dwell times of the inactive and active-like conformations of TM VII are presented graphically in Figure 4 .
Similar smTIRF measurements performed for complexes of b 2 AR with the balanced agonist formoterol or the b-arrestinbiased agonist isoetharine showed that there are also two intensity states, similar to those seen for the apo form ( Figures 2B and  2C) . The mean dwell times of the inactive state (Figure 4 ) are unchanged relative to the apo receptor when either ligand is bound, indicating that these ligands have no effect on the rate of the activation transition. However, the mean dwell times of the activelike state are prolonged in the presence of either ligand (Figure 4) , showing that both ligands retard the deactivation transition. Since agonist ligands are known to stimulate the signaling activity of b 2 AR (Baker, 2010) , these observations are consistent with the independently obtained assignments of the inactive and active-like states of TM VII. The key observation is that the b-arrestin-biased agonist isoetharine prolongs the dwell time of the active-like conformation of TM VII to a significantly greater extent than does the balanced agonist formoterol (Figure 4 ).
DISCUSSION
Fluorescence spectroscopy has previously been used to monitor activation-related conformational changes of TM VI of b 2 AR at both ensemble (Ghanouni et al., 2001; Yao et al., 2009 ) and single-molecule (Lamichhane et al., 2015; Gregorio et al., 2017) levels. However, little was known about the conformational dynamics of TM VII. Here, we have shown that a Cy3 fluorophore can be covalently attached to Cys327, near the cytoplasmic end of TM VII, without disrupting the binding of prototypical b 2 AR ligands to the receptor (Figure 1) . These observations are consistent with the molecular modeling results, which suggest that the Cy3 moiety can be accommodated within the inactive or active receptor conformations, with only minor adjustments around the probe site in the case of the active conformation (Figure 1B) . The modeling results further suggest that the Cy3 moiety is solvent exposed in the inactive receptor conformation ( Figure 1A) but is buried in a restricted environment in the active-like receptor conformation ( Figure 1B) . The latter environment is expected to give rise to PIFE, resulting in higher fluorescence intensity. We observed that the Cy3 intensity stochastically switches between two distinct intensity states in individual receptor molecules the absence of any ligands (Figure 2A) , indicating that TM VII samples both conformations. The ability of the receptor to sample an active-like conformation of TM VII in the absence of any ligands is consistent with the relatively high level of basal (ligand-independent) signaling activity of b 2 AR (Bond et al., 1995) . The higher-intensity state is favored in the presence of either formoterol or isoetharine agonists ( Figures  2B and 2C) , confirming that this state reflects an active-like conformation of TM VII, consistent with the molecular modeling results.
We previously visualized the conformational dynamics of b 2 AR at the single-molecule level using a Cy3 reporter attached to the cytoplasmic end of TM VI (Lamichhane et al., 2015) . In that study, TM VI also exhibited spontaneous transitions between inactive and active-like conformations in the absence of ligands. Combined with these previous observations on TM VI, the present data yield a consistent view of b 2 AR: the receptor is intrinsically dynamic and continually fluctuates between inactive and active-like conformations, even in the absence of ligands. Interestingly, the Cy3 reporter attached to TM VI ex- . The best-fit parameters are t 1 = 345 ± 12 ms, t 2 = 3.2 ± 0.8 s, A 1 = 94% ± 3%, A 2 = 6% ± 2%. (B) Histogram of dwell times in state A for the apo form. The best-fit parameters are t 1 = 208 ± 35 ms, t 2 = 1.6 ± 0.2 s, A 1 = 74% ± 6%, A 2 = 26% ± 4%. (C) State I in the presence of the balanced agonist formoterol (1 mM). The best-fit parameters are t 1 = 303 ± 37 ms, t 2 = 1.7 ± 0.6 s, A 1 = 80% ± 5%, A 2 = 20% ± 5%. (D) State A in the presence of 1 mM formoterol. The best-fit parameters are t 1 = 323 ± 42 ms, t 2 = 2.1 ± 0.2 s, A 1 = 70% ± 4%, A 2 = 30% ± 3%. (E) State I in the presence of 1 mM isoetharine. The best-fit parameters are t 1 = 323 ± 21 ms, t 2 = 2.4 ± 0.6 s, A 1 = 91% ± 20%, A 2 = 9% ± 20%. (F) State A in the presence of the b-arrestin-biased ligand isoetharine (1 mM). The best-fit parameters are t 1 = 455 ± 62 ms, t 2 = 2.5 ± 0.3 s, A 1 = 74% ± 6%, A 2 = 26% ± 4%.
hibited lower fluorescence intensity in the active-like state compared with the inactive state (Lamichhane et al., 2015) , whereas here we have observed the opposite behavior when Cy3 is attached to TM VII. This difference can be rationalized by the crystal structures of b 2 AR complexes with an antagonist (Cherezov et al., 2007) and an agonist (Rasmussen et al., 2011) , which showed that the positions of TM VI and TM VII were the results of outward and inward movements, respectively, during activation.
Earlier studies with several different GPCRs suggest that TM VII mediates signaling bias and receptor coupling to b-arrestin (Rahmeh et al., 2012; Liu et al., 2012; Kang et al., 2015; Che et al., 2018; McCorvy et al., 2018) . Hence, a major goal of the present study was to compare the influence of both balanced and b-arrestin-biased ligands on the conformational dynamics of TM VII. A previous NMR spectroscopic study of b 2 AR labeled with a 19 F probe at C327 in TM VII (same site as used here) revealed two resonances with distinct chemical shifts, attributed to inactive and active-like conformations . Binding of the b-arrestin-biased agonist isoetharine produced a near-complete population shift toward the active-like state of TM VII, whereas the inactive state was still significantly populated ($35%) in the presence of the balanced agonist formoterol . This is in sharp contrast with the effects of these ligands on TM VI, where the populations of the active-like conformational state are $50% regardless of which ligand is bound . Here, we have now elucidated the kinetics basis for the observed ligand bias at TM VII. In principle, agonist binding could destabilize the inactive state of TM VII, stabilize the active state, or act through both mechanisms. The real-time kinetics data obtained in the present study now readily distinguish among these possibilities. The mean dwell times of the inactive state of TM VII are unchanged relative to apo-b 2 AR when either formoterol or isoetharine are present, indicating that the bound agonists neither stabilize nor destabilize this conformation (Figure 4) . However, the mean dwell times of the active-like conformation are prolonged when either agonist is bound (Figure 4) , indicating that the population shifts induced by agonist binding are specifically due to kinetic stabilization of the active-like receptor conformation. Notably, the b-arrestin-biased agonist isoetharine prolongs the dwell time of the active-like state of TM VII to a greater extent than does the balanced agonist formoterol, explaining the large population shift toward this state observed in the 19 F NMR studies .
In the cellular context, signaling occurs in the presence of effector proteins, such as b-arrestin, which is absent in our in vitro experiments. Here we have shown that ligands can control the dwell times of specific receptor conformations in the absence of any effector proteins. By prolonging the dwell time of the active-like conformation of TM VII, a bound b-arrestinbiased ligand, such as isoetharine, would extend the time window available for b-arrestin to engage the receptor. Our results suggest that ligands are intrinsically capable of inducing signaling bias by modulating the conformational exchange kinetics of the receptor, which is an additional, new criterion to be considered in drug-discovery projects. Future studies employing the present single-molecule fluorescence system with a range of synthetic and endogenous ligands, with or without b-arrestin present, will further explore the relationship between receptor conformational dynamics and biased signaling. In addition, by varying the lipid composition of the nanodiscs, the present system could also be used to investigate whether specific lipids can modulate the kinetic response of the receptor to balanced or biased ligands.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (downloaded from https://physics.illinois.edu/cplc/software/) was used in combination with IDL software (ITT VIS, version 8.1) to record CCD camera data and generate fluorescence intensity time traces.
Single-Molecule Data Analysis
A small population of receptor-nanodisc aggregates was present on the surface, but these were readily identified by their unusually high fluorescence intensity and were excluded from further analysis. Trajectories displaying reversible intensity fluctuations prior to a single-step photobleaching event were selected for analysis. Each individual emission intensity trajectory was corrected for background and truncated prior to the photobleaching event. Trajectories were fitted with a Hidden Markov model assuming two distinct intensity states, using the program HaMMy (McKinney et al., 2006) . The intensity levels observed before and after each transition were assigned to active or inactive states, based on a chosen threshold value. The dwell times spent in each state prior to transition to the other state were compiled in the form of histograms, using data from multiple receptor molecules. The resulting histograms were fitted with a double-exponential function (Equation 1) by a non-linear regression algorithm using the Igor Pro software:
where N(t) is the number of counts with dwell time t, A 1 and t 1 are the amplitude and mean dwell time of component 1, respectively, and A 2 and t 2 are the corresponding quantities for component 2. The Igor software reports the best-fit values of each parameter, as well as the associated standard deviation.
QUANTIFICATION AND STATISTICAL ANALYSIS
Described in Method Details.
DATA AND CODE AVAILABILITY
This study did not generate any unique data sets or codes.
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